Toxicology Laboratory Industry Analysis in North America

Toxicology Laboratory Industry Analysis in North America by Alcohol, Amphetamines, Barbiturates, Benzodiazepines, Opiates/Opioids, Tricyclic Antidepressants, and Z Drugs from 2024 to 2034

Analysis of Toxicology Laboratory Industry Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

author

Author:

Md Sanaullah

author

Editor:

Anushree Karale

Toxicology Laboratory Industry Analysis in North America
  • FACT9738MR
  • 18 Jan 2024
  • Healthcare
  • 170 Pages
  • 30 Tables
  • 90 Figures
  • Base Value(2019): 141.0 Mn
  • Forecast Value (2034): 695.1 Mn
  • CAGR (2034): 11.3%

Table of Content

  • 1. Executive Summary
  • 2. Market Overview
  • 3. Market Background
  • 4. North America Industry Analysis 2019 to 2023 and Forecast, 2024 to 2034
  • 5. North America Industry Analysis 2019 to 2023 and Forecast 2024 to 2034, By Drug Class
    • 5.1. Amphetamines
    • 5.2. Alcohol
    • 5.3. Barbiturates
    • 5.4. Benzodiazepines
    • 5.5. Illicit Drugs
    • 5.6. Opiates/Opioids
    • 5.7. Tricyclic’s Antidepressants
    • 5.8. Z Drugs
  • 6. North America Industry Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product
    • 6.1. Reagent and Kits
      • 6.1.1. ELISA
      • 6.1.2. PCR
      • 6.1.3. Enzyme Multiplied Immunoassay Technique (EMIT)
      • 6.1.4. Radio Immuno-sorbent Assay (RIA)
    • 6.2. Instruments
      • 6.2.1. Immunochemistry Analyzers
      • 6.2.2. PCR Machine
      • 6.2.3. Gas Chromatography/Mass Spectrometry (GS/MS)
      • 6.2.4. High Performance Liquid Chromatography (HPLC)
  • 7. North America Industry Analysis 2019 to 2023 and Forecast 2024 to 2034, By Sample
    • 7.1. Urine
    • 7.2. Blood
    • 7.3. Hair
    • 7.4. Oral Fluid
  • 8. North America Industry Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User
    • 8.1. Hospitals
    • 8.2. Clinics
    • 8.3. Diagnostic Laboratories
    • 8.4. Forensic Laboratories
    • 8.5. Rehabilitation Centres
  • 9. North America Industry Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
    • 9.1. U.S.
    • 9.2. Canada
  • 10. U.S. Industry Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
  • 11. Canada Industry Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
  • 12. Market Structure Analysis
  • 13. Competition Analysis
    • 13.1. Thermo Fisher Scientific, Inc
    • 13.2. Danaher Corporation
    • 13.3. Agilent Technologies
    • 13.4. Alere, Inc.
    • 13.5. Bio Rad Laboratories Inc.
    • 13.6. Neogen Corporation
    • 13.7. Redwood Toxicology Laboratory
    • 13.8. Principle Laboratory
    • 13.9. Pacific Toxicology Laboratories
    • 13.10. Medical Toxicology Laboratory, LLC
  • 14. Assumptions & Acronyms Used
  • 15. Research Methodology

List Of Table

Table 01: North America Industry Value (US$ Million) Forecast by Region, 2019 to 2034

Table 02: North America Industry Volume (Units) Forecast by Region, 2019 to 2034

Table 03: North America Industry Value (US$ Million) Forecast by Drug Class, 2019 to 2034

Table 04: North America Industry Volume (Units) Forecast by Drug Class, 2019 to 2034

Table 05: North America Industry Value (US$ Million) Forecast by Product, 2019 to 2034

Table 06: North America Industry Volume (Units) Forecast by Product, 2019 to 2034

Table 07: North America Industry Value (US$ Million) Forecast by Sample, 2019 to 2034

Table 08: North America Industry Volume (Units) Forecast by Sample, 2019 to 2034

Table 09: North America Industry Value (US$ Million) Forecast by End User, 2019 to 2034

Table 10: North America Industry Volume (Units) Forecast by End User, 2019 to 2034

Table 11: U.S. Industry Value (US$ Million) Forecast by Region, 2019 to 2034

Table 12: U.S. Industry Volume (Units) Forecast by Region, 2019 to 2034

Table 13: U.S. Industry Value (US$ Million) Forecast by Drug Class, 2019 to 2034

Table 14: U.S. Industry Volume (Units) Forecast by Drug Class, 2019 to 2034

Table 15: U.S. Industry Value (US$ Million) Forecast by Product, 2019 to 2034

Table 16: U.S. Industry Volume (Units) Forecast by Product, 2019 to 2034

Table 17: U.S. Industry Value (US$ Million) Forecast by Sample, 2019 to 2034

Table 18: U.S. Industry Volume (Units) Forecast by Sample, 2019 to 2034

Table 19: U.S. Industry Value (US$ Million) Forecast by End User, 2019 to 2034

Table 20: U.S. Industry Volume (Units) Forecast by End User, 2019 to 2034

Table 21: Canada Industry Value (US$ Million) Forecast by Region, 2019 to 2034

Table 22: Canada Industry Volume (Units) Forecast by Region, 2019 to 2034

Table 23: Canada Industry Value (US$ Million) Forecast by Drug Class, 2019 to 2034

Table 24: Canada Industry Volume (Units) Forecast by Drug Class, 2019 to 2034

Table 25: Canada Industry Value (US$ Million) Forecast by Product, 2019 to 2034

Table 26: Canada Industry Volume (Units) Forecast by Product, 2019 to 2034

Table 27: Canada Industry Value (US$ Million) Forecast by Sample, 2019 to 2034

Table 28: Canada Industry Volume (Units) Forecast by Sample, 2019 to 2034

Table 29: Canada Industry Value (US$ Million) Forecast by End User, 2019 to 2034

Table 30: Canada Industry Volume (Units) Forecast by End User, 2019 to 2034

List Of Figures

Figure 01: North America Industry Value (US$ Million) by Drug Class, 2024 to 2034

Figure 02: North America Industry Value (US$ Million) by Product, 2024 to 2034

Figure 03: North America Industry Value (US$ Million) by Sample, 2024 to 2034

Figure 04: North America Industry Value (US$ Million) by End User, 2024 to 2034

Figure 05: North America Industry Value (US$ Million) by Country, 2024 to 2034

Figure 06: North America Industry Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 07: North America Industry Volume (Units) Analysis by Country, 2019 to 2034

Figure 08: North America Industry Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 09: North America Industry Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 10: North America Industry Value (US$ Million) Analysis by Drug Class, 2019 to 2034

Figure 11: North America Industry Volume (Units) Analysis by Drug Class, 2019 to 2034

Figure 12: North America Industry Value Share (%) and BPS Analysis by Drug Class, 2024 to 2034

Figure 13: North America Industry Y-o-Y Growth (%) Projections by Drug Class, 2024 to 2034

Figure 14: North America Industry Value (US$ Million) Analysis by Product, 2019 to 2034

Figure 15: North America Industry Volume (Units) Analysis by Product, 2019 to 2034

Figure 16: North America Industry Value Share (%) and BPS Analysis by Product, 2024 to 2034

Figure 17: North America Industry Y-o-Y Growth (%) Projections by Product, 2024 to 2034

Figure 18: North America Industry Value (US$ Million) Analysis by Sample, 2019 to 2034

Figure 19: North America Industry Volume (Units) Analysis by Sample, 2019 to 2034

Figure 20: North America Industry Value Share (%) and BPS Analysis by Sample, 2024 to 2034

Figure 21: North America Industry Y-o-Y Growth (%) Projections by Sample, 2024 to 2034

Figure 22: North America Industry Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 23: North America Industry Volume (Units) Analysis by End User, 2019 to 2034

Figure 24: North America Industry Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 25: North America Industry Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 26: North America Industry Attractiveness by Drug Class, 2024 to 2034

Figure 27: North America Industry Attractiveness by Product, 2024 to 2034

Figure 28: North America Industry Attractiveness by Sample, 2024 to 2034

Figure 29: North America Industry Attractiveness by End User, 2024 to 2034

Figure 30: North America Industry Attractiveness by Country, 2024 to 2034

Figure 31: U.S. Industry Value (US$ Million) by Drug Class, 2024 to 2034

Figure 32: U.S. Industry Value (US$ Million) by Product, 2024 to 2034

Figure 33: U.S. Industry Value (US$ Million) by Sample, 2024 to 2034

Figure 34: U.S. Industry Value (US$ Million) by End User, 2024 to 2034

Figure 35: U.S. Industry Value (US$ Million) by Region, 2024 to 2034

Figure 36: U.S. Industry Value (US$ Million) Analysis by Region, 2019 to 2034

Figure 37: U.S. Industry Volume (Units) Analysis by Region, 2019 to 2034

Figure 38: U.S. Industry Value Share (%) and BPS Analysis by Region, 2024 to 2034

Figure 39: U.S. Industry Y-o-Y Growth (%) Projections by Region, 2024 to 2034

Figure 40: U.S. Industry Value (US$ Million) Analysis by Drug Class, 2019 to 2034

Figure 41: U.S. Industry Volume (Units) Analysis by Drug Class, 2019 to 2034

Figure 42: U.S. Industry Value Share (%) and BPS Analysis by Drug Class, 2024 to 2034

Figure 43: U.S. Industry Y-o-Y Growth (%) Projections by Drug Class, 2024 to 2034

Figure 44: U.S. Industry Value (US$ Million) Analysis by Product, 2019 to 2034

Figure 45: U.S. Industry Volume (Units) Analysis by Product, 2019 to 2034

Figure 46: U.S. Industry Value Share (%) and BPS Analysis by Product, 2024 to 2034

Figure 47: U.S. Industry Y-o-Y Growth (%) Projections by Product, 2024 to 2034

Figure 48: U.S. Industry Value (US$ Million) Analysis by Sample, 2019 to 2034

Figure 49: U.S. Industry Volume (Units) Analysis by Sample, 2019 to 2034

Figure 50: U.S. Industry Value Share (%) and BPS Analysis by Sample, 2024 to 2034

Figure 51: U.S. Industry Y-o-Y Growth (%) Projections by Sample, 2024 to 2034

Figure 52: U.S. Industry Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 53: U.S. Industry Volume (Units) Analysis by End User, 2019 to 2034

Figure 54: U.S. Industry Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 55: U.S. Industry Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 56: U.S. Industry Attractiveness by Drug Class, 2024 to 2034

Figure 57: U.S. Industry Attractiveness by Product, 2024 to 2034

Figure 58: U.S. Industry Attractiveness by Sample, 2024 to 2034

Figure 59: U.S. Industry Attractiveness by End User, 2024 to 2034

Figure 60: U.S. Industry Attractiveness by Region, 2024 to 2034

Figure 61: Canada Industry Value (US$ Million) by Drug Class, 2024 to 2034

Figure 62: Canada Industry Value (US$ Million) by Product, 2024 to 2034

Figure 63: Canada Industry Value (US$ Million) by Sample, 2024 to 2034

Figure 64: Canada Industry Value (US$ Million) by End User, 2024 to 2034

Figure 65: Canada Industry Value (US$ Million) by Region, 2024 to 2034

Figure 66: Canada Industry Value (US$ Million) Analysis by Region, 2019 to 2034

Figure 67: Canada Industry Volume (Units) Analysis by Region, 2019 to 2034

Figure 68: Canada Industry Value Share (%) and BPS Analysis by Region, 2024 to 2034

Figure 69: Canada Industry Y-o-Y Growth (%) Projections by Region, 2024 to 2034

Figure 70: Canada Industry Value (US$ Million) Analysis by Drug Class, 2019 to 2034

Figure 71: Canada Industry Volume (Units) Analysis by Drug Class, 2019 to 2034

Figure 72: Canada Industry Value Share (%) and BPS Analysis by Drug Class, 2024 to 2034

Figure 73: Canada Industry Y-o-Y Growth (%) Projections by Drug Class, 2024 to 2034

Figure 74: Canada Industry Value (US$ Million) Analysis by Product, 2019 to 2034

Figure 75: Canada Industry Volume (Units) Analysis by Product, 2019 to 2034

Figure 76: Canada Industry Value Share (%) and BPS Analysis by Product, 2024 to 2034

Figure 77: Canada Industry Y-o-Y Growth (%) Projections by Product, 2024 to 2034

Figure 78: Canada Industry Value (US$ Million) Analysis by Sample, 2019 to 2034

Figure 79: Canada Industry Volume (Units) Analysis by Sample, 2019 to 2034

Figure 80: Canada Industry Value Share (%) and BPS Analysis by Sample, 2024 to 2034

Figure 81: Canada Industry Y-o-Y Growth (%) Projections by Sample, 2024 to 2034

Figure 82: Canada Industry Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 83: Canada Industry Volume (Units) Analysis by End User, 2019 to 2034

Figure 84: Canada Industry Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 85: Canada Industry Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 86: Canada Industry Attractiveness by Drug Class, 2024 to 2034

Figure 87: Canada Industry Attractiveness by Product, 2024 to 2034

Figure 88: Canada Industry Attractiveness by Sample, 2024 to 2034

Figure 89: Canada Industry Attractiveness by End User, 2024 to 2034

Figure 90: Canada Industry Attractiveness by Region, 2024 to 2034

Toxicology Laboratory Industry Analysis in North America

Free Sample Buy Report Now

Copyright © Fact.MR All Rights Reserved

An initiative of Eminent Research and Advisory Services